HSD17B3 antibody
GTX114480
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetHSD17B3
Overview
- SupplierGeneTex
- Product NameHSD17B3 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.92 mg/ml
- ConjugateUnconjugated
- Gene ID3293
- Target nameHSD17B3
- Target descriptionhydroxysteroid 17-beta dehydrogenase 3
- Target synonymsEDH17B3, SDR12C2, 17-beta-hydroxysteroid dehydrogenase type 3, 17-beta-HSD 3, 17-beta-HSD3, estradiol 17-beta-dehydrogenase 2, hydroxysteroid dehydrogenase 3, short chain dehydrogenase/reductase family 12C member 2, testicular 17-beta-hydroxysteroid dehydrogenase, testosterone 17-beta-dehydrogenase 3
- HostRabbit
- IsotypeIgG
- Protein IDP37058
- Protein Name17-beta-hydroxysteroid dehydrogenase type 3
- Scientific DescriptionThis isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone. It preferentially uses NADP as cofactor. Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Kobayashi H, Shirasawa N, Naito A. Estrogen synthesis in the stomach of Sprague-Dawley rats: comparison to Wistar rats. Exp Anim. 2021,70(1):63-72. doi: 10.1538/expanim.20-0089Read this paper
- Feng X, Xia K, Ke Q, et al. Transplantation of encapsulated human Leydig-like cells: A novel option for the treatment of testosterone deficiency. Mol Cell Endocrinol. 2021,519:111039. doi: 10.1016/j.mce.2020.111039Read this paper
- Zimmer BM, Howell ME, Wei Q, et al. Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential. Horm Cancer. 2016,7(4):260-71. doi: 10.1007/s12672-016-0268-zRead this paper





